Press release
Global Migraine Therapeutics Market|Eminent Players- Eli Lilly & Company, Teva Pharmaceutical Industries, Alder Biopharmaceuticals
QMI
Get Free Report Sample Copy: http://bit.ly/2n2PVbd
Migraine is a complex debilitating neurological disorder which is often characterized by recurrent severe headaches in one side of the head. It is generally preceded by sensory warning signs and other symptoms such as sensitivity to light and noise, nausea, vomiting, dizziness, etc.
Migraine therapeutics market is expected to witness the advent of first-in-class novel migraine drugs especially meant for patients unresponsive to triptans or ones at risk of cardiovascular disorders. Allergan’s ubrogepant and Eli Lilly’s Lasmiditan are one of the leading migraine drugs based on novel mechanism of action.
This report “Global Migraine Therapeutics Market [By Drug Classes - Triptan, CGRP, Acetylcholine Inhibitors/Neurotoxins, Others; By Region – North America (The US), Europe (The UK, Germany, France, Italy & Spain) and Asia Pacific (Japan) - Outlook 2025]” provides a detailed analysis of the global migraine therapeutics market from qualitative and quantitative outlooks during the forecast period across various therapeutic classes. It also provides coverage on market dynamics with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.
SEGMENTS COVERED
The report provides revenue forecasts for global, regional and country levels. It also provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. For the purpose of research, Quince Market Insights has segmented global migraine therapeutics market report has been segmented on the basis of drug classes and region:-
Get Detailed Table Of Content: http://bit.ly/2orLln6
Therapeutic Class Outlook
• Triptan
• CGRP
• Acetylcholine Inhibitors/Neurotoxins
• Others
Regional Outlook
• North America
• Europe
• Asia Pacific
• Rest Of The World
Buy Now This Report: http://bit.ly/2orMo6w
Vendors Outlook
• Eli Lilly & Company
• Teva Pharmaceutical Industries
• Alder Biopharmaceuticals
• Amgen Inc.
• AbbVie Inc.
• Pfizer Inc.
Contact:
Quince Market Insights
Pune – 411028
Email: sales@quincemarketinsights.com
Phone: + 91-2026992033
About Quince Market Insights:
Quince Market Insights is a global market research and consulting company publishing syndicate studies as well as consulting assignments pertaining to market opportunities that promise high growth in the future. The company also provides information on different research practices such as competitive analysis, product mapping, value chain analysis, etc., assisting clients in strategic decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Migraine Therapeutics Market|Eminent Players- Eli Lilly & Company, Teva Pharmaceutical Industries, Alder Biopharmaceuticals here
News-ID: 1840989 • Views: …
More Releases from QUINCE MARKET INSIGHTS
Premium Bicycles Market Demand, Future Trends, Size, Share and Outlook till 2032 …
Premium Bicycles Market Size & Industry Trends Shaping 2032
A more concise understanding of the Premium Bicycles Market dynamics is provided by QMI. A detailed analysis of market statistics covering both present and emerging trends. The report includes Porter's Five Forces to analyze the prominence of various features such as the understanding of both the suppliers and customers, risks posed by various agents, the strength of competition, and promising emerging businesspersons…
Smart Bicycle Market Detail Analysis focusing on Application, Types and Regional …
Smart Bicycle Market Size & Industry Trends Shaping 2032
A more concise understanding of the Smart Bicycle Market dynamics is provided by QMI. A detailed analysis of market statistics covering both present and emerging trends. The report includes Porter's Five Forces to analyze the prominence of various features such as the understanding of both the suppliers and customers, risks posed by various agents, the strength of competition, and promising emerging businesspersons…
Battery Technology Market: Drivers, Revenue, Application Industry Demand Analysi …
Battery Technology Market Size & Industry Trends Shaping 2032
A more concise understanding of the battery technology market dynamics is provided by QMI. A detailed analysis of market statistics covering both present and emerging trends. The report includes Porter's Five Forces to analyze the prominence of various features such as the understanding of both the suppliers and customers, risks posed by various agents, the strength of competition, and promising emerging businesspersons…
Global Automotive Powertrain Market Size, Share, Industry Forecast 2032 | Toyota …
The most recent report published by QMI indicates that the "Automotive Powertrain Market" is likely to accelerate significantly in the next few years. The Automotive Powertrain Market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The Automotive Powertrain Market study includes information on market factors such as the market dynamics, drivers, restraints, challenges,…
More Releases for Migraine
Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share?
The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way…
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size?
The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,…
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market?
The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes.
Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR…
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market.
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive…
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which…
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC /…
